Tata Elxsi Selected As Certified 3PL Partner for Google Widevine

October 15, 2020

Tata Elxsi, a world-leading design and technology services company, is pleased to announce its selection as a 3PL certification partner for Google Widevine, to deliver secure premium content protection for Broadcast, Media, Consumer Electronics, and Automotive applications.

Tata Elxsi notes this certification partnership further expands Tata Elxsi’s offerings and leadership in the broadcast, media, consumer devices, and automotive domains, and enables leading brands, content distributors, OTT providers and operators with a seamless development, integration, and certification service for Widevine solutions ensuring faster time-to-market for their revenue-generating services.

Google Widevine enables secure premium content protection on any consumer device, utilizing free-to-use, standards-based solutions for OTT, and CAS services. It has been used in over 5 Billion devices today and is trusted by PayTV providers and broadcasters who deliver premium content over an OTT network such as Netflix, HBO, Disney, Amazon Prime, Jio, Warner Bros and more. Through this program, Google plans to scale the adoption of the Widevine CAS solutions by enabling select chosen partners for certification activities.

“In line with the trust our customers and partners have in us, we are delighted to select Tata Elxsi as a Certified 3PL Partner. Tata Elxsi’s strong ecosystem in the Broadcast, OTT, Consumer devices, and Mobility markets, understanding of cloud-native applications, and world class user experience capabilities will help accelerate the adoption of our Widevine solutions by customers. The collaboration between the two teams has been outstanding and will continue to ensure a wonderful customer experience.” said Brian Baker, Senior Director and head of Widevine at Google.

This is the first time the 3PL partnership model has been instituted, and we are delighted to have been selected for this program and extend our partnership with Google and Widevine. This will accelerate the adoption of Widevine solutions by customers and their time to market for new products and revenue-generating services, “said Nitin Pai, Chief Marketing and Strategy Officer, Tata Elxsi.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version